Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate vs actinomycin D for C-section ectopic pregnancy
IRCT20151020024625N16Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methotrexate and actinomycin D in Ectopic pregnancy (EP) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Primary effectiveness of methotrexate vs actinomycin D. Started May 2023; status: completed.
02
Drugs
methotrexateactinomycin D
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on IRCT20151020024625N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151020024625N16.